nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
|
Chen, Haizhu |
|
|
71 |
12 |
p. 3071-3085 |
artikel |
2 |
Checkpoint-inhibitor induced Polyserositis with Edema
|
Zierold, Sarah |
|
|
71 |
12 |
p. 3087-3092 |
artikel |
3 |
Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients
|
Jingushi, Kentaro |
|
|
71 |
12 |
p. 2999-3011 |
artikel |
4 |
Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8+ T‑cells from GzmB mediated self‑destruction
|
Zangari, Brendan |
|
|
71 |
12 |
p. 2899 |
artikel |
5 |
First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience
|
Kreutmair, Stefanie |
|
|
71 |
12 |
p. 2913-2928 |
artikel |
6 |
Functional expression of CD73 on human natural killer cells
|
Chambers, Andrea M. |
|
|
71 |
12 |
p. 3043-3056 |
artikel |
7 |
High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach
|
Han, Myung-Hoon |
|
|
71 |
12 |
p. 3013-3027 |
artikel |
8 |
Immune activation of the monocyte-derived dendritic cells using patients own circulating tumor cells
|
Kolostova, Katarina |
|
|
71 |
12 |
p. 2901-2911 |
artikel |
9 |
Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer
|
Lee, Sung Eun |
|
|
71 |
12 |
p. 3029-3042 |
artikel |
10 |
Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity
|
Chovatiya, Nishant |
|
|
71 |
12 |
p. 2929-2941 |
artikel |
11 |
Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trials
|
Fujiwara, Yu |
|
|
71 |
12 |
p. 2837-2848 |
artikel |
12 |
Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model
|
Varghese, Bindu |
|
|
71 |
12 |
p. 2943-2955 |
artikel |
13 |
In vitro and in vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4+ and CD8+ T-cell epitopes for cancer immunotherapy
|
Tang, Xu-Dong |
|
|
71 |
12 |
p. 2969-2983 |
artikel |
14 |
Natural killer cells and acute myeloid leukemia: promises and challenges
|
Rahmani, Shayan |
|
|
71 |
12 |
p. 2849-2867 |
artikel |
15 |
Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration
|
Moriya, Taiki |
|
|
71 |
12 |
p. 3099-3106 |
artikel |
16 |
Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers
|
Wakiyama, Hiroaki |
|
|
71 |
12 |
p. 2869-2879 |
artikel |
17 |
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study
|
Palassin, Pascale |
|
|
71 |
12 |
p. 3093-3097 |
artikel |
18 |
Targeting tumor extracellular matrix activates the tumor-draining lymph nodes
|
Najibi, Alexander J. |
|
|
71 |
12 |
p. 2957-2968 |
artikel |
19 |
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
|
Zangari, Brendan |
|
|
71 |
12 |
p. 2881-2898 |
artikel |
20 |
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies
|
Moreno, V. |
|
|
71 |
12 |
p. 2985-2998 |
artikel |
21 |
Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8+ T cells
|
Li, Xiang |
|
|
71 |
12 |
p. 3057-3070 |
artikel |